Abstract
Osteoporosis causes bone loss, and makes bone to susceptible to fracture. The main cause of osteoporosis is estrogen deficiency. Estrogen, calcitonin, calcium, vitamin D and antioxidants can be used to prevent osteoporosis. For the treatment of osteoporosis, the potential biological activities of traditional medicines have been subjected to scientific evaluation, since synthetic drugs are considered to have several side effects and they lack efficacy. Therefore, more extensive research should be carried out to investigate the medicinal plants to be used as an alternative treatment for osteoporosis. The present review focuses on the scientific researches on the assessment of anti-osteoporotic activity of medicinal plants.
Keywords: Bone mineral density, medicinal plants, musculoskeletal system, osteoporosis.
Current Drug Targets
Title:Beneficial Effects of Plant Sources on the Treatment of Osteoporosis
Volume: 14 Issue: 13
Author(s): Ipek Süntar and Esra Küpeli Akkol
Affiliation:
- Gazi University, Faculty of Pharmacy, Department of Pharmacognosy, Etiler 06330, Ankara,Turkey.,Turkey
Keywords: Bone mineral density, medicinal plants, musculoskeletal system, osteoporosis.
Abstract: Osteoporosis causes bone loss, and makes bone to susceptible to fracture. The main cause of osteoporosis is estrogen deficiency. Estrogen, calcitonin, calcium, vitamin D and antioxidants can be used to prevent osteoporosis. For the treatment of osteoporosis, the potential biological activities of traditional medicines have been subjected to scientific evaluation, since synthetic drugs are considered to have several side effects and they lack efficacy. Therefore, more extensive research should be carried out to investigate the medicinal plants to be used as an alternative treatment for osteoporosis. The present review focuses on the scientific researches on the assessment of anti-osteoporotic activity of medicinal plants.
Export Options
About this article
Cite this article as:
Süntar Ipek and Akkol Küpeli Esra, Beneficial Effects of Plant Sources on the Treatment of Osteoporosis, Current Drug Targets 2013; 14(13) . https://dx.doi.org/10.2174/13894501113149990205
DOI https://dx.doi.org/10.2174/13894501113149990205 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
In Vivo Bioluminescence Imaging to Assess Pancreatic Islets
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Effects of Peroxyl Radicals on Contractility of Rabbit Aorta and Guinea Pig Atria
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis and Bioactivity Evaluation of Dipeptidyl Peptidase IV Resistant Glucagon-like Peptide-1 Analogues
Protein & Peptide Letters New Strategies and Drugs in the Treatment of Hypertension: Monotherapy or Combination?
Recent Patents on Cardiovascular Drug Discovery Melatonin Modulates Lactation by Regulating Prolactin Secretion Via Tuberoinfundibular Dopaminergic Neurons in the Hypothalamus- Pituitary System
Current Protein & Peptide Science Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Current Medicinal Chemistry Application of Carbon Monoxide for Transplantation
Current Pharmaceutical Biotechnology Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders
Current Medicinal Chemistry Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-analysis
Current Diabetes Reviews Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Indication-oriented Ovulation Induction in Assisted Reproduction
Current Women`s Health Reviews Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
Current Pharmaceutical Design Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma
Anti-Cancer Agents in Medicinal Chemistry Discovery of Novel Candidate Therapeutics and Diagnostics Based on Engineered Human Antibody Domains
Current Drug Discovery Technologies Bioactive Polyphenols from Grapes and Wine Emphasized with Resveratrol
Current Pharmaceutical Design Autoimmunity and Apoptosis - Therapeutic Implications
Current Medicinal Chemistry Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Current Clinical Pharmacology Insulin Therapy for Diabetes Epidemic: A Patent Review
Current Drug Delivery The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design The Occurrence of Veterinary Pharmaceuticals in the Environment: A Review
Current Analytical Chemistry